1. Ferrari AJ, Charlson FJ, Norman RE, Patten SB, Freedman G, Murray CJ, et al. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med. 2013; 10(11):e1001547.
2. World Health Organization. Pharmacological treatment of mental disorders in primary health care. Geneva: World Health Organization;2009.
3. Plante GE. Depression and cardiovascular disease: a reciprocal relationship. Metabolism. 2005; 54(5):Suppl 1. 45–48.
4. Nam M, Heo DS, Jun TY, Lee MS, Cho MJ, Han C, et al. Depression, suicide, and Korean society. J Korean Med Assoc. 2011; 54(4):358–361.
5. Penninx BW. Depression and cardiovascular disease: epidemiological evidence on their linking mechanisms. Neurosci Biobehav Rev. 2017; 74(Pt B):277–286.
6. Joynt KE, Whellan DJ, O'Connor CM. Depression and cardiovascular disease: mechanisms of interaction. Biol Psychiatry. 2003; 54(3):248–261.
7. Bonnet F, Irving K, Terra JL, Nony P, Berthezène F, Moulin P. Anxiety and depression are associated with unhealthy lifestyle in patients at risk of cardiovascular disease. Atherosclerosis. 2005; 178(2):339–344.
8. Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry. 1998; 55(7):580–592.
9. Anda R, Williamson D, Jones D, Macera C, Eaker E, Glassman A, et al. Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults. Epidemiology. 1993; 4(4):285–294.
10. Aromaa A, Raitasalo R, Reunanen A, Impivaara O, Heliövaara M, Knekt P, et al. Depression and cardiovascular diseases. Acta Psychiatr Scand Suppl. 1994; 377:77–82.
11. Nicholson A, Kuper H, Hemingway H. Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J. 2006; 27(23):2763–2774.
12. Kweon S, Kim Y, Jang MJ, Kim Y, Kim K, Choi S, et al. Data resource profile: the Korea National Health and Nutrition Examination Survey (KNHANES). Int J Epidemiol. 2014; 43(1):69–77.
13. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001; 16(9):606–613.
14. Löwe B, Unützer J, Callahan CM, Perkins AJ, Kroenke K. Monitoring depression treatment outcomes with the patient health questionnaire-9. Med Care. 2004; 42(12):1194–1201.
15. Han C, Jo SA, Kwak JH, Pae CU, Steffens D, Jo I, et al. Validation of the Patient Health Questionnaire-9 Korean version in the elderly population: the Ansan Geriatric study. Compr Psychiatry. 2008; 49(2):218–223.
16. Williams N. PHQ-9. Occup Med (Lond). 2014; 64(2):139–140.
17. Shin C, Kim Y, Park S, Yoon S, Ko YH, Kim YK, et al. Prevalence and associated factors of depression in general population of Korea: results from the Korea National Health and Nutrition Examination Survey, 2014. J Korean Med Sci. 2017; 32(11):1861–1869.
18. Manea L, Gilbody S, McMillan D. Optimal cut-off score for diagnosing depression with the Patient Health Questionnaire (PHQ-9): a meta-analysis. CMAJ. 2012; 184(3):E191–E196.
19. Yun JM, Yoo TG, Oh SW, Cho BL, Kim E, Hwang I. Prediction of cardiovascular disease in Korean population: based on health risk appraisal of national health screening program. J Korean Med Assoc. 2017; 60(9):746–752.
20. Hwang I, Kim EY, Lee KH, Cho B. Improvement of the health risk appraisal model and report form of the national health screening program. Public Health Wkly Rep. 2018; 11(14):433–437.
21. Korea Centers for Disease Control and Prevention. Improvement of health risk appraisal (HRA). Cheongju: Korea Centers for Disease Control and Prevention;2017.
22. Korea Centers for Disease Control and Prevention. Consultative manual for 2018 national health screening program. Cheongju: Korea Centers for Disease Control and Prevention;2017.
23. Lam CS, Little WC. Sex and cardiovascular risk: are women advantaged or men disadvantaged? Circulation. 2012; 126(8):913–915.
24. Andrus B, Lacaille D. 2013 ACC/AHA guideline on the assessment of cardiovascular risk. J Am Coll Cardiol. 2014; 63(25 Pt A):2886.
25. Zhao G, Ford ES, Li C, Tsai J, Dhingra S, Balluz LS. Waist circumference, abdominal obesity, and depression among overweight and obese U.S. adults: National Health and Nutrition Examination Survey 2005–2006. BMC Psychiatry. 2011; 11(1):130.
26. Piwoński J, Piwońska A, Sygnowska E. Do depressive symptoms adversely affect the lifestyle? Results of the WOBASZ study. Kardiol Pol. 2010; 68(8):912–918.
27. van Gool CH, Kempen GI, Penninx BW, Deeg DJ, Beekman AT, van Eijk JT. Relationship between changes in depressive symptoms and unhealthy lifestyles in late middle aged and older persons: results from the Longitudinal Aging Study Amsterdam. Age Ageing. 2003; 32(1):81–87.
28. Jonas BS, Franks P, Ingram DD. Are symptoms of anxiety and depression risk factors for hypertension? Longitudinal evidence from the National Health and Nutrition Examination survey I epidemiologic follow-up study. Arch Fam Med. 1997; 6(1):43–49.
29. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001; 24(6):1069–1078.
30. van Reedt Dortland AK, Giltay EJ, van Veen T, van Pelt J, Zitman FG, Penninx BW. Associations between serum lipids and major depressive disorder: results from the Netherlands Study of Depression and Anxiety (NESDA). J Clin Psychiatry. 2010; 71(6):729–736.
31. Tsai YC, Chiu YW, Hung CC, Hwang SJ, Tsai JC, Wang SL, et al. Association of symptoms of depression with progression of CKD. Am J Kidney Dis. 2012; 60(1):54–61.
32. Rottenberg J, Chambers AS, Allen JJ, Manber R. Cardiac vagal control in the severity and course of depression: the importance of symptomatic heterogeneity. J Affect Disord. 2007; 103(1-3):173–179.
33. Licht CM, de Geus EJ, Penninx BW. Dysregulation of the autonomic nervous system predicts the development of the metabolic syndrome. J Clin Endocrinol Metab. 2013; 98(6):2484–2493.
34. Pan A, Keum N, Okereke OI, Sun Q, Kivimaki M, Rubin RR, et al. Bidirectional association between depression and metabolic syndrome: a systematic review and meta-analysis of epidemiological studies. Diabetes Care. 2012; 35(5):1171–1180.
35. Abboud FM, Harwani SC, Chapleau MW. Autonomic neural regulation of the immune system: implications for hypertension and cardiovascular disease. Hypertension. 2012; 59(4):755–762.
36. Knorr U, Vinberg M, Kessing LV, Wetterslev J. Salivary cortisol in depressed patients versus control persons: a systematic review and meta-analysis. Psychoneuroendocrinology. 2010; 35(9):1275–1286.
37. Jokinen J, Nordström P. HPA axis hyperactivity and cardiovascular mortality in mood disorder inpatients. J Affect Disord. 2009; 116(1-2):88–92.
38. Cesari M, Penninx BW, Newman AB, Kritchevsky SB, Nicklas BJ, Sutton-Tyrrell K, et al. Inflammatory markers and onset of cardiovascular events: results from the health ABC study. Circulation. 2003; 108(19):2317–2322.
39. Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010; 67(5):446–457.